Discovering the true signals of disease to power life-changing medicines 

90% of potential drugs fail, often because they lack the genetic evidence to prove they will work. Sequence Bio is on a mission to change that.

By studying the inherited causes of disease, we aim to identify the right drug targets and predictors of disease and treatment response from the start—ensuring transformative medicines reach the people who need them.

In Newfoundland and Labrador, our research is powered by founder effects that bring the genetic drivers of disease into focus.

By pairing these insights with deep clinical and family health histories, we can move beyond association to causal evidence—linking genes to disease with a level of confidence that pushes discovery forward.